Market intelligence, trend analysis and forecasts for the Pharma and Healthcare industries across the regions

Companies / Mexico

Health Budget Crisis Looms In Mexico

July 2006 | Industry News

Reforms aimed at reversing an alarming budget shortfall in Mexico's two public sector healthcare schemes, ISSSTE and IMSSS, appear deadlocked in the country's Senate. The crisis has been provoked by a black hole in pension contributions.

Sorry, you must be a subscriber to view this article in full. If you are a subscriber please login.

[
: *
[
: *

Forgotten your password?

If you would like to subscribe to Americas Pharma & Healthcare Insight and gain instant access to this article, please click here to subscribe.

If you would like to take a trial to Americas Pharma & Healthcare Insight please click on the trial link below.

Related Insight Articles
New Exact Dosing Measures Proposed

Companies / Mexico A prominent Mexican politician has called for reforms of the General Health Law to limit prescription dispensing to the quantities indicated in prescriptions, reduce counterfeiting and limit self-medication....
June 2007
Mexico's Health Spending Remains Low

Companies / Mexico According to surveys published by the OECD, Mexico's health spending is proportionally one of the lowest of all the organisation's member states. The data indicates that health expenditure is only 6.5%...
August 2006
Drug Firms Agree New Supply Plan

Companies / Mexico Pharmaceutical companies have agreed on a plan to supply Mexico's healthcare scheme for low-income citizens, known as the Seguro Popular (SP). The programme - which aims to cover any 'catastrophic' health...
August 2006
Industry Admits Illegal Drug Samples Problem

Companies / Mexico Mexican pharmaceutical industry association AMIIF has defended the use of product samples supplied to doctors, as market regulators consider closer enforcement of measures regulating the practice. The...
August 2006
Merck, Pfizer Get Mexican Approvals

Companies / Mexico US drug giant Pfizer is to market Factive (gemifloxacin), an anti-infective developed by compatriot firm Oscient, in Mexico. The drug is indicated as a five-day therapy for three diseases including pneumonia....
August 2006


All material on this site is protected by international copyright laws and use of this site is subject to our Terms & Conditions.
© 2009 Business Monitor International Ltd
Site powered by WORKSsitebuilder CMS